DE3802040A1 - System zur positiven selektion rekombinanter dna-molekuele - Google Patents
System zur positiven selektion rekombinanter dna-molekueleInfo
- Publication number
- DE3802040A1 DE3802040A1 DE19883802040 DE3802040A DE3802040A1 DE 3802040 A1 DE3802040 A1 DE 3802040A1 DE 19883802040 DE19883802040 DE 19883802040 DE 3802040 A DE3802040 A DE 3802040A DE 3802040 A1 DE3802040 A1 DE 3802040A1
- Authority
- DE
- Germany
- Prior art keywords
- dna
- rglb
- protein
- dna sequence
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004511 Recombinant DNA Proteins 0.000 title claims abstract description 19
- 108020004414 DNA Proteins 0.000 claims abstract description 74
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 38
- 239000012634 fragment Substances 0.000 claims abstract description 34
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 26
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 230000000694 effects Effects 0.000 claims abstract description 18
- 101100236749 Escherichia coli (strain K12) mcrB gene Proteins 0.000 claims description 52
- 101150025294 rglB gene Proteins 0.000 claims description 52
- 239000013612 plasmid Substances 0.000 claims description 51
- 108060004795 Methyltransferase Proteins 0.000 claims description 50
- 239000013598 vector Substances 0.000 claims description 40
- 102000016397 Methyltransferase Human genes 0.000 claims description 34
- 101710163270 Nuclease Proteins 0.000 claims description 22
- 238000010367 cloning Methods 0.000 claims description 12
- 241000588724 Escherichia coli Species 0.000 claims description 11
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 9
- 101100344662 Escherichia coli (strain K12) mcrA gene Proteins 0.000 claims description 7
- 101150065259 rglA gene Proteins 0.000 claims description 7
- 101100346446 Escherichia coli (strain K12) mrr gene Proteins 0.000 claims description 3
- 238000003776 cleavage reaction Methods 0.000 description 23
- 230000007017 scission Effects 0.000 description 23
- 241001646716 Escherichia coli K-12 Species 0.000 description 22
- 230000035772 mutation Effects 0.000 description 14
- 108091008146 restriction endonucleases Proteins 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 11
- 230000009466 transformation Effects 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 229960000723 ampicillin Drugs 0.000 description 6
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 238000010276 construction Methods 0.000 description 5
- 231100000350 mutagenesis Toxicity 0.000 description 5
- 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 239000000287 crude extract Substances 0.000 description 4
- 208000016861 hereditary angioedema type 3 Diseases 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 230000011987 methylation Effects 0.000 description 4
- 238000007069 methylation reaction Methods 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 102000055027 Protein Methyltransferases Human genes 0.000 description 3
- 108700040121 Protein Methyltransferases Proteins 0.000 description 3
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 231100000518 lethal Toxicity 0.000 description 3
- 230000001665 lethal effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 102100030684 Sphingosine-1-phosphate phosphatase 1 Human genes 0.000 description 2
- 101710168942 Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- CKOMXBHMKXXTNW-UHFFFAOYSA-N 6-methyladenine Chemical compound CNC1=NC=NC2=C1N=CN2 CKOMXBHMKXXTNW-UHFFFAOYSA-N 0.000 description 1
- 241000702005 Bacillus phage SPP1 Species 0.000 description 1
- 241000702009 Bacillus phage SPR Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010073254 Colicins Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 101100033261 Escherichia coli (strain K12) rclA gene Proteins 0.000 description 1
- 241001522878 Escherichia coli B Species 0.000 description 1
- 241000644323 Escherichia coli C Species 0.000 description 1
- 241001524679 Escherichia virus M13 Species 0.000 description 1
- 241000701533 Escherichia virus T4 Species 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19883802040 DE3802040A1 (de) | 1988-01-25 | 1988-01-25 | System zur positiven selektion rekombinanter dna-molekuele |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19883802040 DE3802040A1 (de) | 1988-01-25 | 1988-01-25 | System zur positiven selektion rekombinanter dna-molekuele |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3802040A1 true DE3802040A1 (de) | 1989-08-03 |
| DE3802040C2 DE3802040C2 (cg-RX-API-DMAC7.html) | 1989-11-23 |
Family
ID=6345916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19883802040 Granted DE3802040A1 (de) | 1988-01-25 | 1988-01-25 | System zur positiven selektion rekombinanter dna-molekuele |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE3802040A1 (cg-RX-API-DMAC7.html) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997001639A3 (en) * | 1995-06-27 | 1997-06-12 | Univ Sheffield | Selection of recombinant molecules |
| GB2316947A (en) * | 1995-06-27 | 1998-03-11 | Univ Sheffield | Selection of recombinant molecules |
| EP0871715A4 (cg-RX-API-DMAC7.html) * | 1994-05-24 | 1998-10-21 |
-
1988
- 1988-01-25 DE DE19883802040 patent/DE3802040A1/de active Granted
Non-Patent Citations (1)
| Title |
|---|
| gene 33, S. 103-119, 1985 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0871715A4 (cg-RX-API-DMAC7.html) * | 1994-05-24 | 1998-10-21 | ||
| EP1431388A3 (en) * | 1994-05-24 | 2004-11-10 | New England Biolabs, Inc. | A method for direct cloning of nuclease genes in E.Coli |
| WO1997001639A3 (en) * | 1995-06-27 | 1997-06-12 | Univ Sheffield | Selection of recombinant molecules |
| GB2316947A (en) * | 1995-06-27 | 1998-03-11 | Univ Sheffield | Selection of recombinant molecules |
| GB2316947B (en) * | 1995-06-27 | 1999-09-08 | Univ Sheffield | Selection of recombinant molecules |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3802040C2 (cg-RX-API-DMAC7.html) | 1989-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69631118T2 (de) | Dna-integration durch transposition | |
| DE69721282T2 (de) | In vitro transpositionsystem unter verwendung einer modifizierten tn5 transposase | |
| DE68927486T2 (de) | Verfahren zur Integration eines bestimmten Gens ins bakterielle Chromosom und durch dieses Verfahren erhaltenes Bakterium | |
| DE68924174T2 (de) | Verfahren zur rekombination in vivo von teilweise homologen dns-sequenzen. | |
| DE69033388T2 (de) | Alkalisches proteolytisches enzym und verfahren zur herstellung | |
| DE3751923T2 (de) | Verfahren zur Klonierung von Restriktions-Modifikationssystemen | |
| DE69922032T2 (de) | Verfahren zur herstellung von insertionsmutanten | |
| DE69033616T2 (de) | Riboflavin überproduzierende Bakterienstämme | |
| EP0069697A2 (de) | Herstellung und Anwendung von Plasmiden mit Genen für die Biosynthese von L-Prolin | |
| DE19812103A1 (de) | Verfahren zur Synthese von Nucleinsäuremolekülen | |
| WO1988001641A1 (fr) | Micro-organismes et plasmides pour la formation de mono-oxygenase d'acide acetique de 2,4-dichlorophenoxy (2,4-d), et procede pour la fabrication de ces plasmides et souches | |
| DE69430005T2 (de) | Konstruktion von pasteurella haemolitika mutanten | |
| EP0460673A1 (de) | Rekombinantes Restriktionsenzym Sau3AI kodierendes DNS | |
| DE3382607T2 (de) | Plasmide mit konditionalem unkontrolliertem replikationsverhalten. | |
| DE69331757T2 (de) | Klonieren und Expression von Restriktionsendonukleasen und Modifikationsmethylasen von Karyophanon | |
| DE60014640T2 (de) | Genetische kaskaderegulierte expression von klonierten genen | |
| CH640268A5 (en) | Process for the preparation of filamentous hybrid phages, novel hybrid phages and their use | |
| DE3802040C2 (cg-RX-API-DMAC7.html) | ||
| DE3586652T2 (de) | Kloniertes streptomyces-beta-galaktosidase-promoter-fragment. | |
| DE3751564T2 (de) | Verfahren zur Stabilisierung eines Plasmids, das in einem Bakterienstamm enthalten ist und der erhaltene Stamm. | |
| DE69327822T2 (de) | Verfahren zur Klonierung und zur Herstellung der AatII-Restriktionsendonuklease und -methylase | |
| DE69028890T2 (de) | Ergiebige Herstellung von Protease-Mutanten | |
| EP0543344B1 (de) | Mikroorganismen zur Stabilisierung von Plasmiden | |
| DE3783812T2 (de) | Fuer saeuerungsmittel geeignetes vektorplasmid, insbesondere fuer molkereisaeuerungsmittel. | |
| DE69230825T2 (de) | Genexpression in bazillen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |